EAF2 and prostate carcinoma: Overexpression of EAF2 induced apoptosis in cultured prostate cancer cells as well as in prostate cancer xenograft tumors [9], and EAF2 knockdown in LNCaP cells enhanced the expression of androgen receptor (AR)-target genes, cell proliferation, and migration [12].